Charles River Labs Intl Stock
Charles River Labs Intl Stock
There is nearly no change for the Charles River Labs Intl stock today. Compared to yesterday it only changed by -€0.200.
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | -0.080% | 20.276% | 19.569% | 90.491% | 41.558% | 24.758% | -28.118% |
| Ligand Pharmaceuticals | 1.560% | -4.580% | -9.420% | 96.850% | 50.602% | 296.825% | 166.923% |
| United Therapeutics | 1.170% | -0.800% | -6.885% | 72.317% | 4.447% | 105.384% | 155.029% |
| Ionis Pharmaceuticals Inc. | 1.670% | 0.524% | -5.919% | 36.364% | -29.370% | 32.414% | 47.420% |
Comments
Charles River Laboratories International (CRL) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Show more
Ratings data for CRL provided by MarketBeat